Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   malnutrition
  

Disease ID 1228
Disease malnutrition
Definition
disorder of nutrition due to unbalanced or insufficient diet or to defective assimilation or utilization of nutrients.
Synonym
acquired deficiency
deficiencies disorders nutritional
deficiencies nutritional
deficiency -nutritional
deficiency disorders nutritional
deficiency nutritional
deficiency state
deficit
deficit, nos
dietary deficiency
insufficiency - dietary
malnourished
malnourishment
malnourishments
malnutrition [disease/finding]
malnutrition nos
malnutrition nos (disorder)
nutrition deficiency nos
nutrition poor
nutritional defic
nutritional deficiencies
nutritional deficiencies (disorder)
nutritional deficiency
nutritional deficiency (disorder)
nutritional deficiency (finding)
nutritional deficiency disorder
nutritional deficiency disorder (disorder)
nutritional deficiency disorder, nos
nutritional deficiency finding
nutritional deficiency nos
nutritional deficiency nos (disorder)
nutritional deficiency state
nutritional deficiency, nos
poor nutrition
underfed
undernourished
undernourished (finding)
undernutrition
undernutrition (disorder)
undernutrition [ambiguous]
undernutrition syndrome
undernutrition syndrome, nos
undernutrition, nos
unspecified nutritional deficiency
DOID
UMLS
C0162429
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:181)
C0023890  |  cirrhosis  |  19
C0002871  |  anemia  |  16
C0023890  |  liver cirrhosis  |  13
C0011991  |  diarrhea  |  12
C0028754  |  obesity  |  11
C0023895  |  liver disease  |  10
C0032285  |  pneumonia  |  10
C0011991  |  diarrhoea  |  10
C0035078  |  renal failure  |  9
C0022806  |  kwashiorkor  |  8
C0011570  |  depression  |  8
C0022661  |  chronic kidney disease  |  8
C0022658  |  kidney disease  |  8
C0022658  |  renal disease  |  8
C0024523  |  malabsorption  |  7
C0162429  |  malnourished  |  7
C0004153  |  atherosclerosis  |  7
C0030567  |  parkinson's disease  |  6
C0022661  |  end-stage renal disease  |  6
C0041296  |  tuberculosis  |  6
C0022661  |  chronic renal failure  |  6
C0002871  |  anaemia  |  6
C0018801  |  heart failure  |  5
C0024115  |  pulmonary disease  |  5
C0021390  |  inflammatory bowel disease  |  5
C1561644  |  chronic kidney disease (ckd)  |  5
C0009402  |  colorectal cancer  |  4
C0006625  |  cachexia  |  4
C0003125  |  anorexia nervosa  |  4
C0007113  |  rectal cancer  |  4
C0010674  |  cystic fibrosis  |  4
C0600260  |  obstructive pulmonary disease  |  4
C0011847  |  diabetes  |  4
C0497327  |  dementia  |  4
C0024530  |  malaria  |  4
C0024117  |  chronic obstructive pulmonary disease  |  4
C0149521  |  chronic pancreatitis  |  4
C0242379  |  lung cancer  |  4
C0030293  |  pancreatic insufficiency  |  3
C0036421  |  systemic sclerosis  |  3
C0021831  |  bowel disease  |  3
C0023895  |  liver diseases  |  3
C0042373  |  vascular disease  |  3
C0001973  |  alcoholism  |  3
C0022661  |  end stage renal disease  |  3
C0042075  |  urological disorders  |  2
C0027765  |  neurological disorder  |  2
C0020538  |  hypertension  |  2
C0042847  |  vitamin b12 defic  |  2
C0039841  |  thiamine deficiency  |  2
C0003873  |  rheumatoid arthritis  |  2
C0020598  |  hypoglycemia  |  2
C0001173  |  gastric outlet obstruction  |  2
C0018799  |  heart disease  |  2
C0041327  |  pulmonary tuberculosis  |  2
C0017178  |  gastrointestinal disorders  |  2
C0011334  |  caries  |  2
C0026846  |  muscle wasting  |  2
C0023290  |  visceral leishmaniasis  |  2
C0007222  |  cardiovascular disease  |  2
C0021053  |  immune dysfunction  |  2
C1140680  |  ovarian cancer  |  2
C0162429  |  poor nutrition  |  2
C0021831  |  enteropathy  |  2
C1140680  |  ovarian ca  |  2
C0009319  |  colitis  |  2
C0003850  |  arteriosclerosis  |  2
C0003864  |  arthritis  |  2
C0086588  |  marasmus  |  2
C0024117  |  chronic obstructive pulmonary disease (copd)  |  2
C0685938  |  gastrointestinal cancer  |  2
C0036341  |  schizophrenia  |  2
C0042769  |  virus infection  |  2
C0010418  |  cryptosporidiosis  |  2
C0027765  |  neurological disorders  |  2
C0016470  |  food allergies  |  2
C0022658  |  nephropathy  |  2
C0008354  |  cholera  |  2
C0035579  |  rickets  |  2
C0022661  |  end stage renal disease (esrd)  |  2
C0017178  |  gastrointestinal disorder  |  2
C0027765  |  neurological disease  |  1
C0004352  |  autism  |  1
C0031090  |  periodontal disease  |  1
C0010043  |  corneal ulcer  |  1
C0034065  |  pulmonary embolism  |  1
C0042373  |  vascular diseases  |  1
C2316810  |  chronic kidney disease stage 5  |  1
C0019151  |  hepatic encephalopathy  |  1
C0030305  |  pancreatitis  |  1
C0020542  |  pulmonary hypertension  |  1
C0002395  |  alzheimer's disease  |  1
C0024312  |  lymphocytopenia  |  1
C0029456  |  osteoporosis  |  1
C0004623  |  bacterial disease  |  1
C0027765  |  nervous system disease  |  1
C0024623  |  gastric cancer  |  1
C1510471  |  vitamin deficiency  |  1
C0006413  |  burkitt's lymphoma  |  1
C0020676  |  hypothyroidism  |  1
C0013369  |  dysentery  |  1
C0031117  |  peripheral neuropathy  |  1
C0043121  |  wernicke encephalopathy  |  1
C0025007  |  measles  |  1
C0011849  |  diabetes mellitus  |  1
C0021831  |  intestinal disease  |  1
C0238301  |  nasopharyngeal carcinoma  |  1
C0025362  |  mental retardation  |  1
C0878544  |  cardiomyopathy  |  1
C0007789  |  cerebral palsy  |  1
C0008495  |  chorioamnionitis  |  1
C0035579  |  hypovitaminosis d  |  1
C0021843  |  intestinal obstruction  |  1
C0024312  |  lymphopenia  |  1
C0006325  |  bruxism  |  1
C0042847  |  vitamin b12 deficiency  |  1
C0036323  |  schistosomiasis  |  1
C0178238  |  intestinal infection  |  1
C0042850  |  vitamin b deficiency  |  1
C0033677  |  protein-energy malnutrition  |  1
C0024299  |  lymphoma  |  1
C0024523  |  intestinal malabsorption  |  1
C0007570  |  celiac disease  |  1
C0019204  |  hepatocellular carcinoma  |  1
C0008370  |  cholestasis  |  1
C0023891  |  alcoholic cirrhosis  |  1
C0152021  |  congenital heart disease  |  1
C0159069  |  impaired glucose tolerance  |  1
C0018799  |  heart diseases  |  1
C0162429  |  undernutrition  |  1
C0036992  |  short bowel syndrome  |  1
C0948303  |  peritoneal carcinoma  |  1
C0677886  |  epithelial ovarian cancer  |  1
C0014544  |  epilepsy  |  1
C0019196  |  hepatitis c  |  1
C0002895  |  sickle cell anemia  |  1
C0033687  |  proteinuria  |  1
C0013395  |  dyspepsia  |  1
C0021359  |  infertility  |  1
C0699791  |  gastric carcinoma  |  1
C0039614  |  tetanus  |  1
C0007222  |  cardiovascular diseases  |  1
C0004134  |  ataxia  |  1
C0023343  |  leprosy  |  1
C0456909  |  blindness  |  1
C0031154  |  peritonitis  |  1
C0178238  |  intestinal infections  |  1
C0026718  |  mucormycosis  |  1
C0016412  |  folate deficiency  |  1
C0014848  |  achalasia  |  1
C0013473  |  eating disorder  |  1
C0870082  |  hyperkeratosis  |  1
C0442874  |  neuropathy  |  1
C0024899  |  mastocytosis  |  1
C0030499  |  parasitosis  |  1
C0023281  |  leishmaniasis  |  1
C0022116  |  ischemia  |  1
C0009324  |  ulcerative colitis  |  1
C0024115  |  lung disease  |  1
C0019158  |  hepatitis  |  1
C0948265  |  metabolic syndrome  |  1
C0042075  |  urological diseases  |  1
C0010346  |  crohn's disease  |  1
C0151332  |  active tuberculosis  |  1
C0162429  |  nutritional deficiency  |  1
C0032827  |  k deficiency  |  1
C0162429  |  nutritional deficiencies  |  1
C0033626  |  protein deficiency  |  1
C0020456  |  hyperglycemia  |  1
C0021390  |  inflammatory bowel diseases  |  1
C0011603  |  dermatitis  |  1
C0022354  |  obstructive jaundice  |  1
C0017178  |  gastrointestinal disease  |  1
C0009241  |  cognitive disorders  |  1
C0264716  |  chronic heart failure  |  1
C0023890  |  hepatic cirrhosis  |  1
C0003969  |  vitamin c deficiency  |  1
C0041948  |  uremia  |  1
C0037274  |  dermatosis  |  1
C2004461  |  bowel dysfunction  |  1
C0031099  |  periodontitis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
MTHFR  |  4524  |  CTD_human
MTR  |  4548  |  CTD_human
CBS  |  875  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:5)
847  |  CAT  |  infer
1813  |  DRD2  |  infer
1815  |  DRD4  |  infer
2876  |  GPX1  |  infer
6648  |  SOD2  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1228
Disease malnutrition
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:148)
HP:0001903  |  Anemia  |  22
HP:0001394  |  Hepatic cirrhosis  |  19
HP:0003073  |  Hypoalbuminaemia  |  14
HP:0002015  |  Swallowing difficulty  |  14
HP:0003774  |  End-stage renal failure  |  14
HP:0001824  |  Weight loss  |  13
HP:0002014  |  Diarrhea  |  11
HP:0001513  |  Obesity  |  11
HP:0002721  |  Immunodeficiency  |  10
HP:0000083  |  Renal insufficiency  |  9
HP:0002090  |  Pneumonia  |  9
HP:0000716  |  Depression  |  8
HP:0012622  |  Chronic kidney disease  |  8
HP:0002621  |  Atherosclerosis  |  7
HP:0002024  |  Intestinal malabsorption  |  7
HP:0001518  |  Small for gestational age  |  7
HP:0001510  |  Growth deficiency  |  7
HP:0002664  |  Neoplasia  |  7
HP:0002039  |  Anorexia  |  7
HP:0001635  |  Congestive heart failure  |  6
HP:0001297  |  Cerebral vascular events  |  6
HP:0000969  |  Dropsy  |  6
HP:0012531  |  Pain  |  5
HP:0001511  |  Prenatal onset growth retardation  |  5
HP:0006280  |  Chronic pancreas inflammation  |  4
HP:0004326  |  Cachexia  |  4
HP:0100543  |  Cognitive deficits  |  4
HP:0001399  |  Liver failure  |  4
HP:0006510  |  Chronic obstructive pulmonary disease  |  4
HP:0000726  |  Dementia  |  4
HP:0011968  |  Feeding difficulties  |  3
HP:0001324  |  Muscular weakness  |  3
HP:0002527  |  Falls  |  3
HP:0002719  |  infections, recurrent  |  3
HP:0002028  |  Chronic diarrhea  |  3
HP:0100806  |  Sepsis  |  3
HP:0002900  |  Hypokalemia  |  3
HP:0002013  |  Emesis  |  2
HP:0001943  |  Hypoglycemia  |  2
HP:0100753  |  Schizophrenia  |  2
HP:0002748  |  Rickets  |  2
HP:0001397  |  Hepatic steatosis  |  2
HP:0040187  |  Neonatal sepsis  |  2
HP:0001263  |  Developmental retardation  |  2
HP:0001888  |  Lymphocytopenia  |  2
HP:0002242  |  Enteropathy  |  2
HP:0003146  |  Decreased circulating cholesterol level  |  2
HP:0012378  |  Fatigue  |  2
HP:0000112  |  Nephropathy  |  2
HP:0000822  |  Hypertension  |  2
HP:0001369  |  Arthritis  |  2
HP:0001370  |  Rheumatoid arthritis  |  2
HP:0002583  |  Colitis  |  2
HP:0004325  |  Low body weight  |  2
HP:0002634  |  Arteriosclerosis  |  2
HP:0003202  |  Neurogenic muscle atrophy, especially in the lower limbs  |  2
HP:0001298  |  Encephalopathy  |  2
HP:0001548  |  Overgrowth  |  2
HP:0002630  |  Fat malabsorption  |  2
HP:0000670  |  Dental caries  |  2
HP:0100785  |  Insomnia  |  1
HP:0001433  |  Enlarged liver and spleen  |  1
HP:0100507  |  Folate deficiency  |  1
HP:0001251  |  Ataxia  |  1
HP:0012597  |  Heavy proteinuria  |  1
HP:0001962  |  Palpitations  |  1
HP:0000618  |  Blindness  |  1
HP:0100280  |  Morbus Crohn  |  1
HP:0002240  |  Enlarged liver  |  1
HP:0000717  |  Autism  |  1
HP:0002665  |  Lymphoma  |  1
HP:0000952  |  Yellow skin  |  1
HP:0000821  |  Underactive thyroid  |  1
HP:0001402  |  Hepatocellular carcinoma  |  1
HP:0001945  |  Fever  |  1
HP:0001268  |  Mental deterioration  |  1
HP:0002615  |  Low blood pressure  |  1
HP:0000708  |  Behavioral problems  |  1
HP:0005214  |  Bowel obstruction  |  1
HP:0012743  |  Central obesity  |  1
HP:0000958  |  Xerosis  |  1
HP:0000789  |  Infertility  |  1
HP:0001507  |  Abnormal growth  |  1
HP:0004905  |  Vitamin A deficiency  |  1
HP:0003074  |  High blood glucose  |  1
HP:0009830  |  Peripheral neuritis  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0001388  |  Joint laxity  |  1
HP:0000939  |  Osteoporosis  |  1
HP:0002480  |  Hepatic encephalopathy  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0100510  |  Vitamin C deficiency  |  1
HP:0012399  |  Bedsore  |  1
HP:0003763  |  Bruxism  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0002027  |  Abdominal pain  |  1
HP:0001733  |  Pancreatic inflammation  |  1
HP:0000819  |  Diabetes mellitus  |  1
HP:0000360  |  Ringing in the ears  |  1
HP:0000078  |  Genital abnormalities  |  1
HP:0003323  |  Muscle weakness, progressive  |  1
HP:0002018  |  Nausea  |  1
HP:0002761  |  Increased joint mobility  |  1
HP:0100502  |  Vitamin B12 deficiency  |  1
HP:0000704  |  Pyorrhea  |  1
HP:0100021  |  Cerebral palsy  |  1
HP:0100749  |  Thoracic pain  |  1
HP:0001946  |  High levels of ketone bodies  |  1
HP:0001638  |  Cardiomyopathy  |  1
HP:0001944  |  Dehydration  |  1
HP:0002204  |  Pulmonary embolism  |  1
HP:0000962  |  Hyperkeratosis  |  1
HP:0001396  |  Cholestasis  |  1
HP:0002180  |  Neurodegeneration  |  1
HP:0002017  |  Nausea and vomiting  |  1
HP:0011096  |  Demyelination  |  1
HP:0002608  |  Celiac disease  |  1
HP:0001249  |  Mental retardation  |  1
HP:0004322  |  Stature below 3rd percentile  |  1
HP:0012804  |  Corneal ulceration  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0011787  |  Central hypothyroidism  |  1
HP:0000833  |  Glucose intolerance  |  1
HP:0002747  |  Respiratory distress due to muscle weakness  |  1
HP:0002571  |  Achalasia  |  1
HP:0003256  |  Coagulopathy  |  1
HP:0002157  |  Azotaemia  |  1
HP:0007018  |  Attention deficits  |  1
HP:0001662  |  Bradycardia  |  1
HP:0011892  |  Vitamin K deficiency  |  1
HP:0001941  |  acidemia  |  1
HP:0001541  |  Ascites  |  1
HP:0001627  |  Congenital heart defects  |  1
HP:0012339  |  Increased resting energy expenditure  |  1
HP:0002791  |  Under breathing  |  1
HP:0000741  |  Apathy  |  1
HP:0003075  |  Hypoproteinemia  |  1
HP:0011947  |  Respiratory infection  |  1
HP:0000093  |  Proteinuria  |  1
HP:0100495  |  Mastocytosis  |  1
HP:0000159  |  Lip abnormality  |  1
HP:0002586  |  Peritonitis  |  1
HP:0002901  |  Hypocalcemia  |  1
HP:0100750  |  Pulmonary atelectasis  |  1
HP:0001410  |  Decreased liver function  |  1
HP:0030731  |  Carcinoma  |  1
HP:0000711  |  Restlessness  |  1
HP:0030828  |  Wheezing  |  1
Disease ID 1228
Disease malnutrition
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:33)
C0009450  |  infection  |  26
C0021311  |  infections  |  20
C0002871  |  anemia  |  16
C0011991  |  diarrhea  |  11
C0235394  |  wasting  |  10
C0023895  |  liver disease  |  10
C0011991  |  diarrhoea  |  8
C0011570  |  depression  |  8
C0021051  |  immunodeficiency  |  7
C0002871  |  anaemia  |  6
C0030193  |  pain  |  5
C0426768  |  o sign  |  5
C0013604  |  oedema  |  4
C0149521  |  chronic pancreatitis  |  4
C0010674  |  cystic fibrosis  |  4
C0850497  |  immune deficiency  |  3
C0021079  |  immunosuppression  |  3
C0235950  |  zinc deficiency  |  3
C0035579  |  rickets  |  2
C0041327  |  pulmonary tuberculosis  |  2
C0042880  |  vitamin k deficiency  |  1
C0013911  |  emaciation  |  1
C0022346  |  jaundice  |  1
C0042847  |  vitamin b12 deficiency  |  1
C0030305  |  pancreatitis  |  1
C0032827  |  k deficiency  |  1
C0036323  |  schistosomiasis  |  1
C0025007  |  measles  |  1
C0016412  |  folate deficiency  |  1
C0020639  |  hypoproteinemia  |  1
C0011849  |  diabetes mellitus  |  1
C0018799  |  heart diseases  |  1
C0878787  |  growth failure  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:20)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11103369092026222592GALTumls:C0162429BeFreeThe correlation of protein content data with activity levels in the blood cells suggests that the S135L missense mutation affects the stability of GALT protein to produce a deficiency state.0.0002714421997GALT934647858CG,T
rs3545725015882283213ALBumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0013572092005AHSG3186620775CT
rs3545725015882283140913PPIAP10umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620775CT
rs35457250158822831465CSRP1umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620775CT
rs35457250158822831401CRPumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620775CT
rs397507444183848424524MTHFRumls:C0162429BeFreeElevated levels of plasma homocysteine, an independent risk factor and a strong predictor of mortality in patients with coronary artery disease (CAD), can result from nutritional deficiencies or genetic errors, including methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms.0.125548392008MTHFR111794407TG
rs491715882283140913PPIAP10umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186619924TC
rs4917158822831465CSRP1umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186619924TC
rs491715882283213ALBumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0013572092005AHSG3186619924TC
rs4917158822831401CRPumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186619924TC
rs4918158822831465CSRP1umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620593GC
rs4918158822831401CRPumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620593GC
rs491815882283140913PPIAP10umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620593GC
rs491815882283213ALBumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0013572092005AHSG3186620593GC
rs70961709158822831401CRPumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620652GA
rs7096170915882283213ALBumls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0013572092005AHSG3186620652GA
rs70961709158822831465CSRP1umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620652GA
rs7096170915882283140913PPIAP10umls:C0162429BeFreeIn a cohort of 258 (161 males) ESRD patients starting renal replacement therapy [glomerular filtration rate (GFR) 6.8 +/- 0.2 mL/min] aged 52 +/- 1 years the following parameters were studied: presence of malnutrition (subjective global assessment), comorbidity [diabetes mellitus and clinical manifest cardiovascular disease (CVD)], carotid plaques (N= 101), hs-CRP, fetuin-A, S-albumin, interleukin (IL)-6, and single nucleotide polymorphisms (SNPs) in the AHSG gene (N= 215) at amino acid positions Thr248Met (C-->T), Thr256Ser (C-->G), Asp276Asn (G-->A), and Arg317Cys (C-->T).0.0005428842005AHSG3186620652GA
rs769214218278482641GCGumls:C0162429BeFreeCatalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame?0.0002714422011CAT1134438170GA
rs76921421827848847CATumls:C0162429BeFreeCatalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame?0.0029099162011CAT1134438170GA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)